
TY  - JOUR
TI  - POSTER DISCUSSION SESSIONS
JO  - Allergy
VL  - 63
IS  - s88
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2008.01759.x
DO  - doi:10.1111/j.1398-9995.2008.01759.x
SP  - 78
EP  - 157
PY  - 2008
ER  - 

TY  - JOUR
C7  - e13384
TI  - Poster Session A
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 227
IS  - S719
SN  - 1748-1708
UR  - https://doi.org/10.1111/apha.13384
DO  - doi:10.1111/apha.13384
SP  - e13384
PY  - 2019
ER  - 

AU  - Frühbeck, Gema
C7  - pp. 47-80
TI  - Over-Nutrition
SN  - 9781405168106
UR  - https://doi.org/10.1002/9781119211945.ch4
DO  - doi:10.1002/9781119211945.ch4
SP  - 47-80
KW  - energy-balance
KW  - obesity
KW  - over-nutrition
KW  - weight loss
PY  - 2019
AB  - Summary The genetic and molecular epidemiology studies carried out in recent decades have considerably enhanced our understanding of the genetic factors contributing to the development of obesity and involved in shaping interindividual differences not only in body weight and adiposity, but in susceptibility to response to energy-balance challenges and the development of several obesity-associated comorbidities. In addition, psychological factors focusing on the association between over-nutrition and behavioural, cognitive, and emotional processes, which may be under genetic or environmental influence, have to be taken into consideration. Weight gain is the consequence of many interacting processes. The majority of surgeons contend that gastric bypass is the bariatric procedure of choice for most patients with severe obesity. In morbidly obese patients refractory to diet and drug therapy, a substantial and sustained weight loss after bariatric surgery is obtained. However, the most effective treatment in the long term is, and will be, obesity prevention.
ER  - 

TY  - JOUR
TI  - Posters
JO  - The FEBS Journal
JA  - FEBS J
VL  - 284
IS  - S1
SN  - 9781405168106
UR  - https://doi.org/10.1111/febs.14174
DO  - doi:10.1111/febs.14174
SP  - 102
EP  - 403
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Fundamental & Clinical Pharmacology
VL  - 26
IS  - s1
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1472-8206.2012.01032.x
DO  - doi:10.1111/j.1472-8206.2012.01032.x
SP  - 1
EP  - 122
PY  - 2012
ER  - 

AU  - Schmitt, Mathieu
C7  - pp. 331-365
TI  - Design and Development of Ocular Formulations for Preclinical and Clinical Trials
SN  - 9783527343966
UR  - https://doi.org/10.1002/9783527812172.ch10
DO  - doi:10.1002/9783527812172.ch10
SP  - 331-365
KW  - clinical trials
KW  - drug administration
KW  - drug delivery
KW  - ocular bioavailability
KW  - ocular routes
KW  - ophthalmology
KW  - preclinical studies
PY  - 2012
AB  - Summary Ocular administration of drugs is a challenge in the field of drug delivery due to the unique characteristics of the eyeball. This chapter provides a general overview of ocular anatomy and routes of administration. It covers recent advances and strategies to overcome ocular drug delivery challenges. Eyes are the extension of the central nervous system (CNS) and are responsible for converting light signals into electrochemical signals to the CNS via the optic nerve. When developing an ophthalmology product, one of the key attributes of the target product profile concerns the choice of the ocular route of administration. Ocular bioavailability is a key challenge for successful ophthalmic product development. Among different physiological factors affecting corneal penetration, a few can directly be influenced during the drug administration. Several active-penetration technologies such as iontophoresis, electroporation, sonotophoresis, or microneedle arrays are currently being investigated in preclinical studies as well as in clinical trials.
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 42
IS  - S30
SN  - 9783527343966
UR  - https://doi.org/10.1002/ppul.20700
DO  - doi:10.1002/ppul.20700
SP  - 202
EP  - 412
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts 1–204
JO  - Hepatology
JA  - Hepatology
VL  - 50
IS  - S4
SN  - 9783527343966
UR  - https://doi.org/10.1002/hep.23300
DO  - doi:10.1002/hep.23300
SP  - 302A
EP  - 401A
PY  - 2009
ER  - 

TY  - JOUR
TI  - Environmental impacts on the genome and epigenome: Mechanisms and risks, October 15–19, 2011
JO  - Environmental and Molecular Mutagenesis
JA  - Environ. Mol. Mutagen.
VL  - 52
IS  - S1
SN  - 9783527343966
UR  - https://doi.org/10.1002/em.20693
DO  - doi:10.1002/em.20693
SP  - S1
EP  - S87
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Allergy
JA  - Allergy
VL  - 68
IS  - s97
SN  - 9783527343966
UR  - https://doi.org/10.1111/all.12252
DO  - doi:10.1111/all.12252
SP  - 498
EP  - 636
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Discussion Session PDS
JO  - Allergy
JA  - Allergy
VL  - 71
IS  - S102
SN  - 9783527343966
UR  - https://doi.org/10.1111/all.12972
DO  - doi:10.1111/all.12972
SP  - 118
EP  - 272
PY  - 2016
ER  - 

TY  - JOUR
TI  - supplement
JO  - Respirology
VL  - 7
IS  - s1
SN  - 9783527343966
UR  - https://doi.org/10.1111/j.1440-1843.2004.supp_2.x
DO  - doi:10.1111/j.1440-1843.2004.supp_2.x
SP  - A15
EP  - A66
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 25
IS  - S4
SN  - 9783527343966
UR  - https://doi.org/10.1111/exd.13200
DO  - doi:10.1111/exd.13200
SP  - 3
EP  - 51
PY  - 2016
ER  - 

TY  - JOUR
TI  - 2017 ACVIM Forum Research Abstract Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 31
IS  - 4
SN  - 9783527343966
UR  - https://doi.org/10.1111/jvim.14778
DO  - doi:10.1111/jvim.14778
SP  - 1225
EP  - 1361
PY  - 2017
ER  - 

TY  - JOUR
TI  - Symposium Abstracts
JO  - Journal of Diabetes Investigation
VL  - 2
IS  - s1
SN  - 9783527343966
UR  - https://doi.org/10.1111/j.2040-1124.2011.00153.x
DO  - doi:10.1111/j.2040-1124.2011.00153.x
SP  - 15
EP  - 38
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session 2
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 11
IS  - S1
SN  - 9783527343966
UR  - https://doi.org/10.1093/eurjhf/hss008
DO  - doi:10.1093/eurjhf/hss008
SP  - S67
EP  - S117
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Session Group I
JO  - Allergy
JA  - Allergy
VL  - 69
IS  - s99
SN  - 9783527343966
UR  - https://doi.org/10.1111/all.12476
DO  - doi:10.1111/all.12476
SP  - 200
EP  - 325
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 43
IS  - S31
SN  - 9783527343966
UR  - https://doi.org/10.1002/ppul.20939
DO  - doi:10.1002/ppul.20939
SP  - 202
EP  - 462
PY  - 2008
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 211
IS  - s697
SN  - 9783527343966
UR  - https://doi.org/10.1111/apha.12362
DO  - doi:10.1111/apha.12362
SP  - 62
EP  - 184
PY  - 2014
ER  - 

TY  - JOUR
C7  - e25187
TI  - HIV Glasgow 2018, 28–31 October 2018, Glasgow, UK
JO  - Journal of the International AIDS Society
JA  - J Intern AIDS Soc
VL  - 21
IS  - S8
SN  - 9783527343966
UR  - https://doi.org/10.1002/jia2.25187
DO  - doi:10.1002/jia2.25187
SP  - e25187
PY  - 2018
ER  - 
